Type 2 Diabetes
‘Making up for lost time’: Managing diabetes disruptions, backlog after COVID-19
The COVID-19 pandemic had a disproportionately disruptive effect on diabetes care compared with other specialties, with delays in care translating to greater risk for cardiovascular and renal complications that will be difficult to reverse.
Weight loss of 15% should be primary goal for most people with type 2 diabetes
Losing 15% of body weight should be a primary treatment goal for most people with type 2 diabetes and could help lead to diabetes remission, according to two speakers.
New EMPEROR-Preserved data show HF benefits regardless of diabetes status
Empagliflozin reduced risk for heart failure hospitalization similarly in people with and without type 2 diabetes and delayed the need for insulin initiation in those with diabetes or prediabetes, data from EMPEROR-Preserved show.
Estimated glucose disposal rate may predict stroke, mortality risk in type 2 diabetes
Low insulin resistance, as measured by estimated glucose disposal rate, is associated with an increased risk for stroke and mortality for adults with type 2 diabetes, according to a speaker.
Liver, pancreatic fat higher in people with type 2 diabetes in all BMI groups
Adults with type 2 diabetes have more liver and intrapancreatic fat across all BMI levels than those without diabetes, and weight loss can help to reduce intra-organ fat to achieve disease remission, according to a speaker.
Larger waistline links to increased liver damage risk in people with type 2 diabetes
Waist circumference independently correlated with the risk for advanced fibrosis among patients with type 2 diabetes, according to a presenter at the European Association for the Study of Diabetes Annual Meeting.
Favorable CV health in middle age may lower lifetime risk for type 2 diabetes
New findings published in the European Journal of Preventive Cardiology highlighted the importance of favorable CV health among middle-aged individuals to prevent type 2 diabetes regardless of genetic disposition.
Weight loss may help adults achieve type 2 diabetes remission, irrespective of BMI
Adults with normal weight and type 2 diabetes may be able to achieve diabetes remission with weight loss, according to data presented at the European Association for the Study of Diabetes virtual meeting.
Alendronate may reduce risk for type 2 diabetes
Alendronate, a drug commonly used to treat osteoporosis, may help protect against type 2 diabetes, according to a presenter at the European Association for the Study of Diabetes virtual meeting.
PCOS-related health care costs approach $8 billion in US annually
The overall economic burden of treating polycystic ovary syndrome in the U.S. exceeds $7.9 billion annually, with almost half the cost attributed to treating the direct costs of stroke and type 2 diabetes.